Literature DB >> 15796379

The use of indomethacin in the treatment of plateau waves: effects on cerebral perfusion and oxygenation.

Roberto Imberti1, Marinella Fuardo, Guido Bellinzona, Michele Pagani, Martin Langer.   

Abstract

OBJECT: Plateau waves are sudden and steep increases in intracranial pressure (ICP) that can develop in patients with cerebral injuries, reduced pressure-volume compensatory reserve, and preserved autoregulation. They are caused by cerebral vasodilation in response to a reduction in cerebral perfusion and are associated with increased cerebral blood volume and reduced cerebral blood flow. The authors evaluated the hypothesis that administration of indomethacin, a potent cerebral arteriolar vasoconstrictor, could interrupt the vicious cycle that occurs during plateau waves, extinguishing these waves and, ultimately, restoring cerebral perfusion and oxygenation.
METHODS: Plateau waves developed in nine patients, seven with severe traumatic brain injury and two with intraparenchymal hemorrhage. One to four episodes of plateau waves per patient were treated with indomethacin (15-20 mg), which was delivered by an intravenous bolus injection. Each patient's mean arterial blood flow (MABP), ICP, cerebral perfusion pressure (CPP), and cerebral tissue PO2 were continuously monitored and the data obtained were stored in a personal computer. Each patient's jugular venous O2 saturation (SjvO2) and venoarterial difference in PCO2 were evaluated by intermittent blood sampling. During five episodes of plateau waves, middle cerebral artery flow velocities were evaluated by transcranial Doppler ultrasonography. Indomethacin extinguished all plateau waves. On average, the ICP decreased from an initial value of 58.9 +/- 11.6 mm Hg to 21.2 +/- 8.6 and 25.8 +/- 13.7 mm Hg after 5 and 10 minutes, respectively (p < 0.01). The MABP did not change significantly. As a consequence the CPP increased by 98 and 81% after 5 and 10 minutes, respectively (p < 0.01). Five and 10 minutes after indomethacin was administered, SjvO2 increased from an initial value of 50 +/- 10.5% to 62 +/- 7.6 and 59.9 +/- 9.3%, respectively (p < 0.01); the cerebral tissue PO2 increased from an initial value of 13.4 +/- 10.6 mm Hg to 23.6 +/- 9.58 and 21.9 +/- 9.2 mm Hg, respectively (p < 0.05); and the venous-arterial PCO2 decreased significantly. The mean and diastolic flow velocities increased significantly, whereas the pulsatility index decreased from 1.39 +/- 0.56 to 1.09 +/- 0.4 at 5 minutes and 1.06 +/- 0.36 at 10 minutes (p < 0.05).
CONCLUSIONS: The findings confirm that plateau waves are caused by vasodilation and show that indomethacin, by constricting the cerebral arteries, is effective in extinguishing plateau waves, ultimately restoring cerebral perfusion and oxygenation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15796379     DOI: 10.3171/jns.2005.102.3.0455

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

Review 1.  Headache in patients with cancer.

Authors:  Samuel A Goldlust; Jerome J Graber; Dana F Bossert; Edward K Avila
Journal:  Curr Pain Headache Rep       Date:  2010-12

2.  Plateau waves in head injured patients requiring neurocritical care.

Authors:  Gianluca Castellani; Christian Zweifel; Dong-Joo Kim; Emmanuel Carrera; Danila K Radolovich; Piotr Smielewski; Peter J Hutchinson; John D Pickard; Marek Czosnyka
Journal:  Neurocrit Care       Date:  2009-06-30       Impact factor: 3.210

Review 3.  Indomethacin for control of ICP.

Authors:  Nick Sader; Frederick A Zeiler; Lawrence M Gillman; Michael West; Colin J Kazina
Journal:  Neurocrit Care       Date:  2015-06       Impact factor: 3.210

Review 4.  Side Effects of Indomethacin in Refractory Post-traumatic Intracranial Hypertension: A comprehensive case study and review.

Authors:  Daniel Agustín Godoy; Pablo David Guerrero Suarez; Luis Rafael Moscote-Salazar; Mario Di Napoli
Journal:  Bull Emerg Trauma       Date:  2017-07

5.  The physiologic effects of indomethacin test on CPP and ICP in severe traumatic brain injury (sTBI).

Authors:  Daniel Agustín Godoy; Erica Alvarez; Ruben Manzi; Gustavo Piñero; Mario Di Napoli
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

Review 6.  Monitoring of brain and systemic oxygenation in neurocritical care patients.

Authors:  Mauro Oddo; Julian Bösel
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

7.  Changes in Cerebral Partial Oxygen Pressure and Cerebrovascular Reactivity During Intracranial Pressure Plateau Waves.

Authors:  Erhard W Lang; Magdalena Kasprowicz; Peter Smielewski; John Pickard; Marek Czosnyka
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

8.  Indomethacin for intracranial hypertension secondary to severe traumatic brain injury in adults.

Authors:  Carlos Martín-Saborido; Jesús López-Alcalde; Agustín Ciapponi; Carlos Enrique Sánchez Martín; Elena Garcia Garcia; Gema Escobar Aguilar; Maria Carolina Palermo; Fernando G Baccaro
Journal:  Cochrane Database Syst Rev       Date:  2019-11-22

Review 9.  Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury.

Authors:  Leif Østergaard; Thorbjørn S Engedal; Rasmus Aamand; Ronni Mikkelsen; Nina K Iversen; Maryam Anzabi; Erhard T Næss-Schmidt; Kim R Drasbek; Vibeke Bay; Jakob U Blicher; Anna Tietze; Irene K Mikkelsen; Brian Hansen; Sune N Jespersen; Niels Juul; Jens C H Sørensen; Mads Rasmussen
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-23       Impact factor: 6.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.